Venus Remedies Ltd files unaudited financial results for six months ended 30 June 2026

What Venus Remedies Ltd announced

Venus Remedies Ltd filed its unaudited financial results for the six‑month period ending 30 June 2026. The filing was made on 20 July 2026 through the Bombay Stock Exchange (BSE) portal, under the corporate filing reference number 526953. The company has not provided a detailed breakdown of the numbers in the public summary; the full PDF contains the complete statement of profit and loss, balance sheet and cash‑flow details.

Financial results overview

The filing states that the results are unaudited, meaning they have not yet been examined by an independent auditor. As per Indian regulations, the company is required to publish audited results for the same period later, typically within 45 days of the statutory deadline. The unaudited figures are intended to give shareholders an early view of the company's performance, but they should be interpreted with caution until the audit is completed.

"Unaudited financial results as on 30th June 2026" – Venus Remedies Ltd, filing dated 20 July 2026.

No quantitative data such as revenue, net profit, earnings per share, or cash‑flow numbers are disclosed in the brief announcement. Interested investors are directed to the attached PDF (BSE filing) for the complete set of numbers.

Key facts at a glance

Why this matters for investors

The submission of unaudited results provides an early snapshot of the company's operational performance for the first half of FY2026‑27. While the figures are not yet verified, they allow shareholders to gauge trends in sales, profitability and cash generation ahead of the audited release. The filing does not indicate any material change in capital structure, dividend policy or corporate actions, so the immediate impact on shareholding is limited to informational transparency.

Investors should monitor subsequent communications for the audited results, which will confirm or adjust the unaudited numbers and may trigger any regulatory disclosures required under the Companies Act, 2013.

Conclusion

Venus Remedies Ltd has complied with its statutory obligation to file unaudited financial results for the six‑month period ended 30 June 2026, filing the documents with BSE on 20 July 2026. The detailed financial figures are contained in the attached PDF, and a audited version will be released later in accordance with regulatory timelines.